Literature DB >> 11499655

Renal biopsy in elderly patients: clinicopathological correlation in 117 Korean patients.

J H Shin1, H J Pyo, Y J Kwon, M K Chang, H K Kim, N H Won, H S Lee, K H Oh, C Ahn, S Kim, J S Lee.   

Abstract

AIM: In the elderly with renal disease, the clinical presentations are frequently inconsistent with the pathologic findings. We tried to clarify the differences in pathological findings between the young and the elderly, in Korea and in Western countries, and the usefulness of a percutaneous renal biopsy in the elderly with renal disease. PATIENTS AND METHODS: We analyzed the clinical presentations and spectrums of renal histopathology by reviewing medical records and renal biopsy reports retrospectively in 117 Korean patients aged 60 years or more with renal disease.
RESULTS: 85 patients had primary renal disease. The remaining 32 patients had renal diseases associated with systemic conditions. Out of the 85 patients with primary renal disease, 61 cases presented as idiopathic nephrotic syndrome. Compared with renal biopsy results of younger adult patients (age 15-59, n = 1,908), membranous nephropathy, crescentic glomerulonephritis, membranoproliferative glomerulonephritis, amyloidosis, light chain disease, and thrombotic thrombocytopenic purpura were more prevalent, but IgA nephropathy and lupus nephritis were less common in the elderly patients. In clinical presentation, nephrotic syndrome and rapidly progressive renal failure were more prevalent, but asymptomatic urinary abnormality was less common in elderly patients. The responsiveness to treatment was good in elderly patients with minimal-change lesion (complete remission in all patients) but poor in crescentic glomerulonephritis, IgA nephropathy, and membranoproliferative glomerulonephritis. From the above findings, the clinical presentation, patterns of histopathology and responsiveness to treatment of elderly Korean patients were similar to those of the younger Korean control group and the Western elderly group.
CONCLUSION: Percutaneous renal biopsy is a useful diagnostic aid and can be used as a therapeutic guideline even in elderly patients with renal disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499655

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  10 in total

Review 1.  The aging kidney: a review--part II.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR).

Authors:  Hitoshi Yokoyama; Hitoshi Sugiyama; Hiroshi Sato; Takashi Taguchi; Michio Nagata; Seiichi Matsuo; Hirofumi Makino; Tsuyoshi Watanabe; Takao Saito; Yutaka Kiyohara; Shinichi Nishi; Hiroyuki Iida; Kunio Morozumi; Atsushi Fukatsu; Tamaki Sasaki; Kazuhiko Tsuruya; Yukimasa Kohda; Makoto Higuchi; Hideyasu Kiyomoto; Shin Goto; Motoshi Hattori; Hiroshi Hataya; Shoji Kagami; Norishige Yoshikawa; Yuichiro Fukasawa; Yoshihiko Ueda; Hiroshi Kitamura; Akira Shimizu; Kazumasa Oka; Naoki Nakagawa; Takafumi Ito; Shunya Uchida; Kengo Furuichi; Izaya Nakaya; Satoshi Umemura; Keiju Hiromura; Mitsuhiro Yoshimura; Nobuhito Hirawa; Takashi Shigematsu; Masafumi Fukagawa; Makoto Hiramatsu; Yoshio Terada; Osamu Uemura; Tetsuya Kawata; Akira Matsunaga; Aki Kuroki; Yasukiyo Mori; Koji Mitsuiki; Haruyoshi Yoshida
Journal:  Clin Exp Nephrol       Date:  2012-10-11       Impact factor: 2.801

3.  Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).

Authors:  Hitoshi Yokoyama; Hitoshi Sugiyama; Ichiei Narita; Takao Saito; Kunihiro Yamagata; Saori Nishio; Shouichi Fujimoto; Noriko Mori; Yukio Yuzawa; Seiya Okuda; Shoichi Maruyama; Hiroshi Sato; Yoshihiko Ueda; Hirofumi Makino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2014-09-18       Impact factor: 2.801

Review 4.  Use of renal biopsy in the elderly.

Authors:  Nasreen Mohamed; Rohan John
Journal:  Int Urol Nephrol       Date:  2010-11-28       Impact factor: 2.370

5.  A clinicopathological study of renal biopsies from 288 elderly patients: analysis based on 4,185 cases.

Authors:  Fan Yang; Bing Li; Wenpeng Cui; Chunyan He; Shujun Liu; Qiaoyan Guo; Man Wu; Lining Miao; Ping Luo
Journal:  Int Urol Nephrol       Date:  2014-12-25       Impact factor: 2.370

6.  Native kidney biopsies in older adults: disease spectrum, long-term kidney and patient survival and safety.

Authors:  Hui Zhuan Tan; Benson Siow; Jason Chon Jun Choo; Alwin Hwai Liang Loh; Fiona Hui Ing Yeo; Irene Mok; Puay Hoon Tan; Choong Meng Chan; Chieh Suai Tan; Keng Thye Woo; Cynthia Ciwei Lim
Journal:  Int Urol Nephrol       Date:  2022-02-12       Impact factor: 2.266

7.  Renal biopsy in the very elderly.

Authors:  Dimitrios-Anestis Moutzouris; Leal Herlitz; Gerald B Appel; Glen S Markowitz; Bernard Freudenthal; Jai Radhakrishnan; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

Review 8.  Management of acute renal failure in the elderly patient: a clinician's guide.

Authors:  Ching M Cheung; Arvind Ponnusamy; John G Anderton
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

9.  The renal histopathology spectrum of elderly patients with kidney diseases: a study of 430 patients in a single Chinese center.

Authors:  Ping Zhu; Fu-de Zhou; Ming-hui Zhao
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

10.  Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland.

Authors:  Agnieszka Perkowska-Ptasinska; Dominika Deborska-Materkowska; Artur Bartczak; Tomasz Stompor; Tomasz Liberek; Barbara Bullo-Piontecka; Anna Wasinska; Agnieszka Serwacka; Marian Klinger; Jolanta Chyl; Michal Kuriga; Robert Malecki; Krzysztof Marczewski; Bogdan Hryniewicz; Tadeusz Gregorczyk; Monika Wieliczko; Stanislaw Niemczyk; Olga Rostkowska; Leszek Paczek; Magdalena Durlik
Journal:  BMC Nephrol       Date:  2016-11-25       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.